SCD silent damage is progressive, independent of the occurrence of vaso-occlusive crises (VOCs). Hemoglobin S (HbS) polymerization drives hemolysis and anemia, that can lead to vasculopathy and organ damage.1-5

A recent meta-analysis explored the impact of hemoglobin (Hb) levels in patients with SCD.6

YOU ARE LEAVING THIS SITE

You are now leaving Global Blood Therapeutic’s site and moving to an external website independently operated and not managed by Global Blood Therapeutics. Global Blood Therapeutics assumes no responsibility for the site(s) you're visiting. If you do not wish to leave this site, click Cancel, or click OK to continue.